Healthcare IT & Genomics
Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.
Reports
Imaging IT Market Intelligence Service - World - 2022/2023
This Market Intelligence Service is an annual subscription that provides ongoing data, insights and analysis on the global opportunity for Imaging IT.
Laboratory Information Systems – World – 2022 - World - 2022
This is a research proposal for a new Market Report on the world Laboratory Information Systems Market due to be published in April 2022.
Structured Reporting Adoption in Imaging IT - World - 2021
This is Signify Research’s 2021 report on the global Structured Reporting Adoption in Imaging IT market.
Imaging IT – Core Report - World - 2021
This report provides world market analysis including: Radiology IT (PACS, RIS, EI), Cardiology IT (CVPACS, CVIS, CV-EI), VNA, IE, Advanced Visualisation and Universal Viewing. Full data analysis in 25 country markets.
Digital Pathology - World - 2021
This is a brochure for Signify Research’s 2021 report on the global market for Digital Pathology published in November 2021.
Cloud Adoption in Imaging IT - World - 2020
This is a brochure for Signify Research’s report on the global market for Cloud Adoption in Imaging IT – World – 2020, published in May 2021.
Analyst Insights
Signify Premium Insight: The Buyers Looking to do a Deal for Dedalus
Signify Premium Insights Subscription Required
12th May 2022 – Since being acquired by Ardian in 2016, Dedalus has picked up numerous other brands granting it significant market share and capability; including in medical imaging IT. Now Ardian is looking to sell the business, but what could a buyer do with such a diverse portfolio?
Signify Premium Insight: The Tightrope Upon Which Lunit Must Walk
Signify Premium Insights Subscription Required
6th May 2022 – Medical Imaging AI developer Lunit has recently received preliminary approval to list publicly in South Korea. The prospect of going public represents a natural next step for the vendor, but it is a step that is also fraught with risk.
Signify Premium Insight: The Concerted Effort that TeraRecon Must Make
Signify Premium Insights Subscription Required
26th April 2022 – ConcertAI has recently secured $150m in Series C funding. While the opportunities for ConcertAI are clear, what are the prospects for TeraRecon? Despite being integrated into ConcertAI, will the AI and AV specialist see any upside from the money?
Signify Premium Insight: Viz.ai and the Perils of Success
Signify Premium Insights Subscription Required
22nd April 2022 – Viz.ai has become medical imaging AI’s latest unicorn after its latest funding round, which saw it raise $100m at a $1.2bn valuation. The funding will mean Viz.ai can work towards its strategic objectives, but, will such figures also attract unwanted attention?
Signify Premium Insight: Autonomous AI Debate Reiterates Importance of Radiologists
Signify Premium Insights Subscription Required
12th April 2022 – After almost dying out, the debate about AI replacing radiologists risks being reignited thanks to the approval of an autonomous rule-out solution from Oxipit. So, does the clearance mean that AI has been transformed?